UBS Group’s Context Therapeutics CNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $242 | Sell |
370
-62
| -14% | -$41 | ﹤0.01% | 8578 |
|
|
2025
Q1 | $264 | Sell |
432
-698,697
| -100% | -$427K | ﹤0.01% | 8543 |
|
|
2024
Q4 | $734K | Buy |
699,129
+697,412
| +40,618% | +$732K | ﹤0.01% | 4444 |
|
|
2024
Q3 | $3.37K | Buy |
+1,717
| New | +$3.37K | ﹤0.01% | 7064 |
|
|
2024
Q1 | – | Sell |
-9,490
| Closed | -$10.7K | – | 8171 |
|
|
2023
Q4 | $10.7K | Buy |
+9,490
| New | +$10.7K | ﹤0.01% | 6218 |
|
|
2023
Q2 | – | Sell |
-5,767
| Closed | -$3.24K | – | 7886 |
|
|
2023
Q1 | $3.24K | Buy |
5,767
+3,012
| +109% | +$1.69K | ﹤0.01% | 7253 |
|
|
2022
Q4 | $1.79K | Buy |
+2,755
| New | +$1.79K | ﹤0.01% | 8591 |
|
|
2022
Q3 | – | Sell |
-3,627
| Closed | -$8K | – | 9262 |
|
|
2022
Q2 | $8K | Buy |
+3,627
| New | +$8K | ﹤0.01% | 7250 |
|